Large pharmaceutical companies are using the Trans-Pacific Partnership (TPP) deal to push for long term monopolies on life-saving biologic medicines, which could be a death sentence for people around the globe diagnosed with cancers and other diseases.
Hear from people who know from their own experience what's at stake and take action.
Biologic medicines have extended the lives of women with breast cancer by years and have saved thousands of lives. Additional biologic medicines in the research pipeline offer hope to people with breast cancer and other cancers.
But large pharmaceutical companies are using the Trans-Pacific Partnership (TPP) deal to push for long term monopolies on these medicines and make more money. They seek a delay before allowing generics or biosimilars. That way they can charge up to hundreds of thousands of dollars per year for the medicines by denying less expensive alternatives that could save lives.
We are calling this proposal the "death sentence clause" because it could sentence many people to unnecessary suffering and early death. People living with cancer around the globe can’t wait for affordable medicines.
For more testimonial videos, click here.
Click the logo to add your name to urge members of Congress to publicly commit now to oppose the TPP when it comes to Congress for a vote
“The Trans-Pacific Partnership (TPP), if passed, would lock in and expand policies that keep cancer medicines unaffordably high and could prevent some of your constituents from accessing the medicines they need to stay alive. I stand with cancer patients, survivors, and their loved ones in urging you to publicly commit now to oppose the TPP when it comes to Congress for a vote.”